Approximately 5–10% of breast cancers have a hereditary component (1), and inherited mutations in high penetrance genes, such as BRCA1 and BRCA2 (2), closely correlate with an increased risk of females of different ethnic and age groups developing breast and/or ovarian cancer (1). This evidence concerns the gene BRCA2 and breast cancer.